Free Trial
Geulah Livshits

Geulah Livshits Analyst Performance

Senior Research Analyst, Biotech at Chardan Capital

Geulah Livshits is a stock analyst at Chardan Capital, covering 31 publicly traded companies across a range of sectors. Over the past year, Geulah Livshits has issued 63 stock ratings, including buy and hold recommendations. While full access to Geulah Livshits' proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Geulah Livshits' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
168 Last 6 Years
Buy Recommendations
97.62% 164 Buy Ratings
Companies Covered
31 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy97.6%164 ratings
Hold2.4%4 ratings
Sell0.0%0 ratings

Out of 168 total stock ratings issued by Geulah Livshits at Chardan Capital, the majority (97.6%) have been Buy recommendations, followed by 2.4% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
93.5% of companies on NASDAQ
29 companies
NYSE
6.5% of companies on NYSE
2 companies

Geulah Livshits, an analyst at Chardan Capital, currently covers 31 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
30 companies
96.8%
Retail/Wholesale
1 company
3.2%

Geulah Livshits of Chardan Capital specializes in stock coverage within the Medical sector, with additional focus on Retail/Wholesale companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
19 companies
61.3%
MED - DRUGS
4 companies
12.9%
PHARMACEUTICAL PREPARATIONS
4 companies
12.9%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
2 companies
6.5%
MED - GENERIC DRG
1 company
3.2%
CATALOG & MAIL - ORDER HOUSES
1 company
3.2%

About Geulah Livshits

Dr. Geulah Livshits is a Senior Research Analyst at Chardan covering biotech companies, with a focus on gene editing and oncology. Dr. Geulah Livshits joined Chardan in the spring of 2018, after a career as an academic scientist. Prior to joining Chardan, Dr. Livshits was a Postdoctoral Research Fellow in the laboratory of Dr. Scott Lowe at Memorial Sloan Kettering Cancer Center, where she developed CRISPR and RNAi approaches to study pancreatic cancer in vivo and in organoid models. Dr. Livshits conducted her thesis research in the laboratory of Dr. Elaine Fuchs at The Rockefeller University, where she studied mechanisms of skin development and regeneration. Her doctoral and postdoctoral work has been published in peer-reviewed academic journals including Nature, Nature Medicine, Nature Biotechnology, eLife, PNAS, and Human Gene Therapy. Dr. Livshits received her BS from Brandeis University, her PhD from The Rockefeller University, and was a Postdoctoral Research Fellow at Memorial Sloan Kettering Cancer Center.
Follow on LinkedIn

Geulah Livshits' Ratings History at Chardan Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
8/22/2025Lower Price Target$145.70$216.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
8/20/2025Reiterated Rating$3.43$11.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
8/15/2025Boost Price Target$46.10$60.00Buy
Metagenomi, Inc. stock logo
MGX
Metagenomi
8/15/2025Lower Price Target$1.86$11.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
8/15/2025Lower Price Target$4.72$15.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
8/14/2025Reiterated Rating$6.10$15.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
8/14/2025Reiterated Rating$3.04$13.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
8/12/2025Reiterated Rating$5.53$25.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
8/12/2025Boost Price Target$2.91$10.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
8/11/2025Lower Price Target$2.86$11.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
8/11/2025Lower Price Target$10.79$60.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
8/8/2025Lower Price Target$2.64$20.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
8/8/2025Lower Price Target$3.79$10.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
8/8/2025Reiterated Rating$1.58$12.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
8/7/2025Reiterated Rating$0.67$9.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
8/5/2025Reiterated Rating$134.94$219.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
8/5/2025Reiterated Rating$55.59$82.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
8/1/2025Reiterated Rating$4.50$25.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
7/25/2025Reiterated Rating$150.00$219.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
7/24/2025Lower Price Target$3.21$12.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
7/23/2025Reiterated Rating$3.13$25.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
7/3/2025Reiterated Rating$4.31$25.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
6/26/2025Reiterated Rating$46.39$82.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
6/24/2025Reiterated Rating$6.70$120.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/18/2025Reiterated Rating$1.82$13.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
6/12/2025Reiterated Rating$2.81$12.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
5/29/2025Boost Price Target$2.44$9.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/28/2025Lower Price Target$2.33$17.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
5/19/2025Lower Price Target$2.77$15.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
5/19/2025Lower Price Target$1.29$12.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/16/2025Boost Price Target$6.72$46.00Buy
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
5/16/2025Lower Price Target$0.56$6.00Buy
Metagenomi, Inc. stock logo
MGX
Metagenomi
5/15/2025Lower Price Target$1.50$12.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
5/13/2025Lower Price Target$2.63$20.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
5/9/2025Reiterated Rating$8.28$68.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
5/9/2025Reiterated Rating$0.44$9.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
5/9/2025Lower Price Target$1.76$25.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/9/2025Lower Price Target$6.97$45.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
5/9/2025Lower Price Target$3.08$25.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
5/7/2025Reiterated Rating$139.47$219.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/7/2025Lower Price Target$33.21$82.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
5/6/2025Reiterated Rating$1.25$13.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
5/2/2025Reiterated Rating$3.25$12.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
4/9/2025Initiated Coverage$20.51$50.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
4/8/2025Lower Price Target$1.79$22.00Buy
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
3/25/2025Reiterated Rating$4.09$25.00Buy
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
3/24/2025Lower Price Target$0.56$7.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
3/24/2025Reiterated Rating$1.80$13.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
3/20/2025Boost Price Target$2.00$16.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
3/12/2025Lower Price Target$0.54$9.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/7/2025Reiterated Rating$5.42$16.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
3/4/2025Lower Price Target$8.51$120.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
3/4/2025Lower Price Target$4.14$28.00Buy
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
3/3/2025Lower Price Target$4.24$30.00Buy
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
3/3/2025Reiterated Rating$2.52$15.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
2/28/2025Lower Price Target$9.49$54.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
2/28/2025Lower Price Target$9.92$68.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
2/26/2025Reiterated Rating$1.62$7.00Buy
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
2/20/2025Boost Price Target$176.17$218.00Buy
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
2/19/2025Boost Price Target$5.30$16.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/13/2025Lower Price Target$43.30$84.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
2/11/2025Lower Price Target$5.32$30.00Buy
CARGO Therapeutics, Inc. stock logo
CRGX
CARGO Therapeutics
1/30/2025Downgrade$13.19Neutral